 |
23 Diseases |  |
0 Trials |
|
0 Trials |  |
2 News |  |
- lintuzumab-gelonin conjugate (Hum-195/rGel) / Targa Therap
Enrollment change, Metastases: Evaluation of the Anti-CD-33 Immunotoxin Hum-195/rGel in Patients With Advanced Myeloid Malignancies (clinicaltrials.gov) - Feb 19, 2013
P1, N=28, Completed, Sponsor: M.D. Anderson Cancer Center
N=36 --> 28
- lintuzumab-gelonin conjugate (Hum-195/rGel) / Targa Therap
Trial completion, Metastases: Evaluation of the Anti-CD-33 Immunotoxin Hum-195/rGel in Patients With Advanced Myeloid Malignancies (clinicaltrials.gov) - Feb 19, 2013
P1, N=28, Completed, Sponsor: M.D. Anderson Cancer Center
N=36 --> 28 Active, not recruiting --> Completed